Search Results for: Pharma 40 A New Initiative
Articles
Leading CDMO PCI Pharma Services Releases Inaugural Comprehensive ESG Report March 27, 2024
PCI Pharma Services (PCI) has released its first Environmental, Social & Governance (ESG) Report. A detailed overview of PCI’s multifaceted...EXECUTIVE INTERVIEW - Samsung Biologics: Exploring The Evolving Biopharma Landscape January 26, 2024
Kevin Sharp, Senior VP & Head of Sales for Samsung Biologics, discusses the evolving biopharma space, exploring current challenges, and the demand for sustainable solutions.
PHARMACOVIGILANCE AUTOMATION - Improving CRO Efficiency Through Automation January 26, 2024
Emmanuel Belabe says many CROs believe they’ve reached a breaking point as they work to keep up with rising case volumes, data complexities, and changing regulations. To combat these pressures, CROs need access to modern pharmacovigilance (PV) automation that promotes flexibility, scalability, efficiency, and cost-effectiveness.
Natco Pharma Limited Completes Transition of DASH Pharmaceuticals Into Natco Pharma USA, Furthering Strategic Presence in the US January 2, 2024
Natco Pharma Limited recently announced DASH Pharmaceuticals, a company that markets, sells, and distributes generic pharmaceutical products, has officially transitioned to….
PHARMACEUTICAL GLOBALIZATION - Navigating Opportunities & Obstacles December 4, 2023
Jürgen Hönig says rapid globalization of the pharmaceutical industry has created new complexities as companies navigate different regulations and government policies, but there are many reasons for optimism, including harmonization, collaboration, and convergence.
OKYO Pharma Achieves 90% Enrollment in 240-Patient Phase 2 Clinical Trial of OK-101 to treat Dry Eye Disease August 30, 2023
OKYO Pharma Limited recently announced it has enrolled and randomized 90% of the patients in its 240-patient Phase 2 multi-center,...IMMUNOLOGY - Innovation Gathers Momentum Amid New Scientific & Technological Breakthroughs May 1, 2023
Patrick Larcier, PhD, says research is entering a new era in immunology with treatments for pathologies that previously had few or no options and looks at the latest trends and what is on the horizon for 2023 and beyond.
SPECIAL FEATURE - PFS & Parenteral Drug Delivery: Self-Injection is Very Much the “New Normal” May 2, 2022
Contributor Cindy H. Dubin showcases how leading CDMOs and drug delivery developers are responding to current market trends to create ergonomic technologies that are patient friendly, easy to use, reduce needle anxiety, and feature improved packaging materials.
Geocann & Averix Bio Form Strategic Partnership to Supply Global Marketplace With Pharmaceutical API Phytocannabinoid Ingredients Formulated With Proven Delivery System April 13, 2022
Geocann recently announced a strategic partnership with Averix Bio that will bring US-produced API phytocannabinoid ingredients and clinically proven bioavailable...Adial Pharmaceuticals Announces Closing of $10 Million Financing February 16, 2022
Adial Pharmaceuticals, Inc. recently announced the closing of its previously announced registered direct offering, whereby a single accredited institutional investor purchased approximately….
OKYO Pharma Announces Successful Completion of Pre-IND Meeting With FDA on the Development of OK-101 to Treat Dry Eye Disease February 15, 2022
OKYO Pharma Limited recently announced the successful completion of a pre-IND (Investigational New Drug) meeting with the US FDA regarding...CordenPharma Collaborates With PeptiSystems on Continuous Peptide Manufacturing & Green Chemistry January 18, 2022
Due to the promising, yet underutilized potential of Green Chemistry and continuous manufacturing synthesis approaches gaining traction in the wider pharmaceutical community, CordenPharma recently announced a collaboration with PeptiSystems, a Swedish-based developer of….
EXECUTIVE INTERVIEW - Pharmaceutics International, Inc: Getting Back to its Roots March 1, 2021
Sridhar Krishnan, Pii’s Senior Vice President, Operations and Strategic Initiatives, discusses how manufacturing is not solely where Pii wanted to be, so the company made a concerted effort to get back to its CDMO roots.
New Incentives & Benefits Can Boost R&D Ecosystem for New Drug Development in India April 1, 2020
India has recently sought feedback from the top pharmaceutical companies to make regulatory changes that offer specific tax benefits for...CONTINUOUS MANUFACTURING - Continuous Manufacturing in Pharmaceuticals: Implications for the Generics Market November 25, 2019
Kamna Jhamb, PhD, says the highly regulated nature of the pharmaceutical sector, and the low-risk-taking nature of this market, are the two main factors that have restrained the implementation of novel methods of manufacturing by pharmaceutical industries. However, the burgeoning demand for complex and innovative therapies and rising competition have led pharmaceutical manufacturers to reconsider their methods of manufacturing.
Lonza Launches Early-Intermediates Supply Initiative for Small-Molecule APIs September 20, 2018
Lonza Pharma & Biotech recently announced the launch of its pharmaceutical early-intermediates supply initiative. The initiative leverages chemical production facilities...Pharma 4.0 – A New Initiative to Help Design the Pharma Facility of the Future June 6, 2018
The pharma industry is continuously evolving which creates value for both the industry itself and the patients that rely on the ever-more varied and targeted drugs it manufacturers. An initiative that is strongly reflective of this evolution and one actively affecting the industry itself is Pharma 4.0.
Vifor Pharma & ChemoCentryx Announce Expansion of Avacopan Agreement February 20, 2017
Vifor Pharma and ChemoCentryx, Inc. recently announced that Vifor Pharma has gained rights to commercialize avacopan in Asia, including Japan...Lonza to Acquire Capsugel to Create Leading Integrated Solutions Provider to the Global Pharma & Consumer Healthcare Industries December 14, 2016
Lonza Group AG, KKR, and Capsugel S.A. recently announced they have entered into a definitive agreement under which Lonza will...Catalent Biologics Collaborates With PATH Malaria Vaccine Initiative to Create Antibodies for Malaria Vaccine R&D December 13, 2016
Catalent Pharma Solutions recently announced it has signed an agreement with PATH, an international non-profit organization and a leader in...
